COX7B2 inhibitors are a category of chemical compounds specifically designed to target and inhibit the activity of the COX7B2 protein. The COX7B2 protein, a component of the cytochrome c oxidase complex, plays a pivotal role in the electron transport chain within the mitochondria, which is crucial for the aerobic production of ATP. By inhibiting COX7B2, these compounds effectively disrupt the normal function of the cytochrome c oxidase complex, leading to a reduction in mitochondrial respiration and, consequently, a decrease in the synthesis of ATP. The specific inhibition of COX7B2 by these compounds is achieved through binding to the active site of the protein or to allosteric sites that alter the protein's conformation and functionality. This precise mechanism of action is critical as it ensures that the inhibitors exert their effects directly on the target protein, thereby reducing off-target effects and increasing the specificity of the inhibition.
The design of COX7B2 inhibitors is informed by the detailed understanding of the COX7B2 protein structure and its role within the mitochondrial electron transport chain. These inhibitors are characterized by their ability to bind to the COX7B2 protein with high affinity, which is essential for their inhibitory function. The binding is typically non-covalent, involving hydrogen bonds, van der Waals forces, and hydrophobic interactions, which can be reversed upon the dissociation of the inhibitor from the protein. This reversible nature of the inhibition allows for control over the extent and duration of the COX7B2 activity suppression. The molecular architecture of COX7B2 inhibitors is such that it complements the structure of the COX7B2 protein, ensuring that the interaction is both stable and effective in hindering the normal enzymatic activity of the protein. Through the inhibition of COX7B2, these compounds directly affect the final steps of the electron transport chain, demonstrating their critical role in the modulation of mitochondrial function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
Rotenone is an inhibitor of mitochondrial electron transport chain complex I. COX7b2 is a subunit of cytochrome c oxidase, which is part of complex IV. By inhibiting complex I, rotenone reduces the electron flow, which indirectly diminishes the activity of complex IV and thus COX7b2 function. | ||||||
Antimycin A | 1397-94-0 | sc-202467 sc-202467A sc-202467B sc-202467C | 5 mg 10 mg 1 g 3 g | $55.00 $63.00 $1675.00 $4692.00 | 51 | |
Antimycin A specifically inhibits the mitochondrial electron transport chain at complex III. This action results in the buildup of electrons at complexes I and II, leading to reduced electron flow to complex IV, where COX7b2 is active, thereby decreasing its functional activity. | ||||||
Sodium azide | 26628-22-8 | sc-208393 sc-208393B sc-208393C sc-208393D sc-208393A | 25 g 250 g 1 kg 2.5 kg 100 g | $43.00 $155.00 $393.00 $862.00 $90.00 | 8 | |
Sodium azide is a potent inhibitor of cytochrome c oxidase (complex IV) by binding to the heme cofactor within the enzyme. This directly inhibits COX7b2, as it is a component of complex IV, leading to decreased oxidative phosphorylation. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc has been shown to inhibit cytochrome c oxidase by binding to its catalytic site. As COX7b2 is a subunit of this complex, zinc binding can indirectly inhibit its activity by affecting the overall complex structure and function. | ||||||
Oligomycin | 1404-19-9 | sc-203342 sc-203342C | 10 mg 1 g | $149.00 $12495.00 | 18 | |
Oligomycin inhibits ATP synthase by blocking its proton channel, which is necessary for ATP production. This results in a feedback inhibition of the electron transport chain and indirect inhibition of COX7b2 activity due to reduced demand for its activity. | ||||||
2-Thenoyltrifluoroacetone | 326-91-0 | sc-251801 | 5 g | $37.00 | 1 | |
TTFA is an inhibitor of mitochondrial complex II. By inhibiting complex II, it can indirectly lead to reduced electron supply to complex IV and thereby decrease the activity of COX7b2. | ||||||